BlackRock Amends Globus Medical Stake, Maintains Significant Holding
Ticker: GMED · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 1237831
| Field | Detail |
|---|---|
| Company | Globus Medical Inc (GMED) |
| Form Type | SC 13G/A |
| Filed Date | Jan 24, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, medical-devices
TL;DR
**BlackRock still owns a big chunk of Globus Medical, signaling institutional confidence.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 24, 2024, disclosing its ownership of Class A Common Stock in Globus Medical Inc. as of December 31, 2023. This amendment, number 12, indicates BlackRock's continued significant institutional holding in the medical device company. This matters to investors because BlackRock, a major institutional investor, maintains a substantial stake, signaling its long-term confidence in Globus Medical's prospects, which could influence other investors' perceptions and the stock's stability.
Why It Matters
BlackRock's continued large ownership in Globus Medical Inc. suggests institutional confidence, which can provide a sense of stability and attract other investors to the stock.
Risk Assessment
Risk Level: low — This filing is a routine update from a major institutional investor, indicating stable ownership rather than a significant change that would introduce new risks.
Analyst Insight
An investor should note BlackRock's consistent institutional ownership as a potential indicator of long-term stability for Globus Medical Inc., but should also conduct their own due diligence beyond this filing.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- Globus Medical Inc. (company) — the subject company whose stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 24, 2024 (date) — the filing date of the SC 13G/A amendment
- Class A Common Stock (security) — the type of shares owned by BlackRock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'Amendment No: 12' sections.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., as clearly identified under '(1)Names of reporting persons. BlackRock, Inc.' in the filing.
What is the subject company whose securities are being reported?
The subject company is GLOBUS MEDICAL INC, as stated under 'Name of Issuer' and 'COMPANY CONFORMED NAME: GLOBUS MEDICAL INC'.
What is the CUSIP number for the securities reported?
The CUSIP number for the Class A Common Stock of Globus Medical Inc. is 379577208, as listed under 'CUSIP No. 379577208'.
What was the date of the event that required this filing?
The date of the event which required this filing was December 31, 2023, as specified under 'Date of Event Which Requires Filing of this Statement'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding GLOBUS MEDICAL INC (GMED).